Skip to content

IGC PHARMA, INC.: 10-Q filed 2016-02-16

What IGC PHARMA, INC. reported in its quarterly report filed 2016-02-16 (fiscal Q3 2016): 45 published measures, 120 facts as tagged in accession 0001185185-16-003719.

This filing

Form
10-Q (quarterly report)
Filed
2016-02-16
Fiscal period
fiscal Q3 2016
Accession
0001185185-16-003719 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All IGC PHARMA, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2015-12-3118,402,880USD
At 2015-03-3120,331,459USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2015-12-314,743,648USD
At 2015-03-315,581,677USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2015-12-3113,089,530USD
At 2015-03-3114,233,855USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2015-12-31607,636USD
At 2015-03-31824,492USD
At 2014-12-311,118,015USD
At 2014-03-311,026,565USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2015-10-01 to 2015-12-31-402,684USD92
2015-04-01 to 2015-12-31-1,384,547USD275
2014-10-01 to 2014-12-31-590,114USD92
2014-04-01 to 2014-12-31-2,695,520USD275

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2015-04-01 to 2015-12-313,253USD275
2014-04-01 to 2014-12-31-2,127,597USD275

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2015-04-01 to 2015-12-31806USD275
2014-04-01 to 2014-12-31882,351USD275

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2015-10-01 to 2015-12-311,084,651USD92
2015-04-01 to 2015-12-314,999,045USD275
2014-10-01 to 2014-12-312,542,192USD92
2014-04-01 to 2014-12-315,423,872USD275

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2015-04-01 to 2015-12-31-267,060USD275
2014-04-01 to 2014-12-312,822,032USD275

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2015-04-01 to 2015-12-3135,271USD275
2014-04-01 to 2014-12-31-716,857USD275

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2015-12-31-48,827,425USD
At 2015-03-31-47,333,955USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2015-10-01 to 2015-12-3116,224,906shares92
2015-04-01 to 2015-12-3116,224,906shares275
2014-10-01 to 2014-12-3112,462,413shares92
2014-04-01 to 2014-12-3112,462,413shares275

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2015-10-01 to 2015-12-3116,224,906shares92
2015-04-01 to 2015-12-3116,224,906shares275
2014-10-01 to 2014-12-3112,462,413shares92
2014-04-01 to 2014-12-3112,462,413shares275

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2015-10-01 to 2015-12-31-0.02USD/shares92
2015-04-01 to 2015-12-31-0.09USD/shares275
2014-10-01 to 2014-12-31-0.05USD/shares92
2014-04-01 to 2014-12-31-0.22USD/shares275

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2015-10-01 to 2015-12-31-0.02USD/shares92
2015-04-01 to 2015-12-31-0.09USD/shares275
2014-10-01 to 2014-12-31-0.05USD/shares92
2014-04-01 to 2014-12-31-0.22USD/shares275

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2015-10-01 to 2015-12-310USD92
2015-04-01 to 2015-12-310USD275
2014-10-01 to 2014-12-310USD92
2014-04-01 to 2014-12-310USD275

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2015-12-316,976,006USD
At 2015-03-317,784,447USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2015-04-01 to 2015-12-3199,000USD275
2014-04-01 to 2014-12-31341,127USD275

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2015-10-01 to 2015-12-31-374,869USD92
2015-04-01 to 2015-12-31-1,140,429USD275
2014-10-01 to 2014-12-31-499,146USD92
2014-04-01 to 2014-12-31-2,414,424USD275

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2015-12-313,441,530USD
At 2015-03-314,477,732USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2015-10-01 to 2015-12-3150,819USD92
2015-04-01 to 2015-12-31179,502USD275
2014-10-01 to 2014-12-3161,957USD92
2014-04-01 to 2014-12-31202,876USD275

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2015-12-311,280,772USD
At 2015-03-312,374,177USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2015-12-31982,782USD
At 2015-03-31982,782USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2015-12-31761,784USD
At 2015-03-31993,296USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2015-12-31651,154USD
At 2015-03-31709,649USD

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2015-10-01 to 2015-12-31878,858USD92
2015-04-01 to 2015-12-314,423,226USD275
2014-10-01 to 2014-12-312,343,062USD92
2014-04-01 to 2014-12-314,966,863USD275

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2015-10-01 to 2015-12-31437,717USD92
2015-04-01 to 2015-12-311,268,474USD275
2014-10-01 to 2014-12-31544,551USD92
2014-04-01 to 2014-12-312,413,665USD275

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2015-12-3117,120,002shares
At 2015-03-3114,766,333shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2015-12-3164,169,820USD
At 2015-03-3163,479,918USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2015-12-31-2,254,577USD
At 2015-03-31-1,913,585USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2015-12-3113,659,232USD
At 2015-03-3114,749,782USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2015-12-3115,918,282USD
At 2015-03-3116,541,783USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2015-12-318,942,276USD
At 2015-03-318,757,336USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2015-12-31263,969USD
At 2015-03-31306,131USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2015-12-31410,163USD
At 2015-03-31434,284USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2015-12-311,014,740USD
At 2015-03-311,009,889USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2015-12-31247,750USD
At 2015-03-31422,252USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2015-12-311,420,956USD
At 2015-03-311,950,295USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2015-10-01 to 2015-12-31-444,830USD92
2015-04-01 to 2015-12-31-1,438,799USD275
2014-10-01 to 2014-12-31-598,996USD92
2014-04-01 to 2014-12-31-2,724,567USD275

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2015-10-01 to 2015-12-31142,945USD92
2015-04-01 to 2015-12-31447,774USD275
2014-10-01 to 2014-12-31153,725USD92
2014-04-01 to 2014-12-31457,768USD275

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2015-10-01 to 2015-12-31-19,212USD92
2015-04-01 to 2015-12-31-118,939USD275
2014-10-01 to 2014-12-31-39,503USD92
2014-04-01 to 2014-12-31-111,351USD275

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2015-04-01 to 2015-12-310USD275
2014-04-01 to 2014-12-310USD275

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2015-04-01 to 2015-12-31332,104USD275
2014-04-01 to 2014-12-312,999,430USD275

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2015-04-01 to 2015-12-31-210,772USD275
2014-04-01 to 2014-12-31-20,094USD275

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2015-04-01 to 2015-12-31-159,349USD275
2014-04-01 to 2014-12-31-592,216USD275

Inspect the source

Entity
IGC PHARMA, INC. / CIK 0001326205
Captured
2026-09-19T11:17:33.392Z
SEC response SHA-256
b5e6159ba110e204ee8261b531c546158153a9053fcdb3ca873d1eff8c2a793e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001326205.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))